TLC Announces TLC599 Agreement with Endo
One of the largest deals seen in Taiwan’s biotech sector SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE via SEAPRWire.com) — TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that it has entered a commercialization agreement with Endo International […]